These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21562434)

  • 21. Convection-enhanced delivery in the treatment of malignant glioma.
    Lopez KA; Waziri AE; Canoll PD; Bruce JN
    Neurol Res; 2006 Jul; 28(5):542-8. PubMed ID: 16808887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
    Ferguson S; Lesniak MS
    Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Convection-enhanced delivery of targeted toxins for malignant glioma.
    Hall WA; Sherr GT
    Expert Opin Drug Deliv; 2006 May; 3(3):371-7. PubMed ID: 16640497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma.
    Weber FW; Floeth F; Asher A; Bucholz R; Berger M; Prados M; Chang S; Bruce J; Hall W; Rainov NG; Westphal M; Warnick RE; Rand RW; Rommell F; Pan H; Hingorani VN; Puri RK
    Acta Neurochir Suppl; 2003; 88():93-103. PubMed ID: 14531567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.
    Sampson JH; Brady ML; Petry NA; Croteau D; Friedman AH; Friedman HS; Wong T; Bigner DD; Pastan I; Puri RK; Pedain C
    Neurosurgery; 2007 Feb; 60(2 Suppl 1):ONS89-98; discussion ONS98-9. PubMed ID: 17297371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology.
    Wagner S; Erdlenbruch B; Längler A; Gnekow A; Kühl J; Albani M; Völpel S; Bucsky P; Emser A; Peters O; Wolff JE
    Cancer; 2004 Apr; 100(8):1750-7. PubMed ID: 15073866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I-II trial of weekly topotecan in the treatment of recurrent cervical carcinoma.
    Puls LE; Phillips B; Schammel C; Hunter JE; Griffin D
    Med Oncol; 2010 Jun; 27(2):368-72. PubMed ID: 19381891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.
    Kunwar S; Chang SM; Prados MD; Berger MS; Sampson JH; Croteau D; Sherman JW; Grahn AY; Shu VS; Dul JL; Husain SR; Joshi BH; Pedain C; Puri RK
    Neurosurg Focus; 2006 Apr; 20(4):E15. PubMed ID: 16709020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
    Sanson M; Ameri A; Monjour A; Sahmoud T; Ronchin P; Poisson M; Delattre JY
    Eur J Cancer; 1996 Dec; 32A(13):2229-35. PubMed ID: 9038603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models.
    Kikuchi T; Saito R; Sugiyama S; Yamashita Y; Kumabe T; Krauze M; Bankiewicz K; Tominaga T
    J Neurosurg; 2008 Nov; 109(5):867-73. PubMed ID: 18976076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Convection-Enhanced Delivery.
    Mehta AM; Sonabend AM; Bruce JN
    Neurotherapeutics; 2017 Apr; 14(2):358-371. PubMed ID: 28299724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant convection-enhanced delivery for the treatment of brain tumors.
    Kreatsoulas D; Damante M; Cua S; Lonser RR
    J Neurooncol; 2024 Jan; 166(2):243-255. PubMed ID: 38261143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.
    Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK
    Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convection-Enhanced Delivery for Management of Malignant Gliomas.
    Prabhu SS
    Prog Neurol Surg; 2018; 32():152-158. PubMed ID: 29990981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future of convection-enhanced delivery in the treatment of brain tumors.
    Bidros DS; Liu JK; Vogelbaum MA
    Future Oncol; 2010 Jan; 6(1):117-25. PubMed ID: 20021213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke.
    Friedman HS; Kerby T; Fields S; Zilisch JE; Graden D; McLendon RE; Houghton PJ; Arbuck S; Cokgor I; Friedman AH
    Cancer; 1999 Mar; 85(5):1160-5. PubMed ID: 10091802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of weekly topotecan in the treatment of heavily pretreated recurrent epithelial ovarian and primary peritoneal cancer: the Kaohsiung Chang Gung experience.
    Hu CF; Ou YC; Fu HC; Chang Chien CC; Tsai CC; Wu CH; Lin H
    Taiwan J Obstet Gynecol; 2015 Feb; 54(1):43-7. PubMed ID: 25675918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience.
    Upadhyayula PS; Spinazzi EF; Argenziano MG; Canoll P; Bruce JN
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33396668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Convection-Enhanced Drug Delivery in the Treatment of Malignant Gliomas.
    Tykocki T; Miękisiak G
    World Neurosurg; 2016 Jun; 90():172-178. PubMed ID: 26898499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.